{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:14:01Z","timestamp":1788984841474,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Cantabria Labs Difa Cooper","award":["unrestricted grant"],"award-info":[{"award-number":["unrestricted grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13555-026-01881-0","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:09:59Z","timestamp":1786608599000},"page":"4705-4718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral Retinol, Alone or Combined with Medical Photoprotection, in Patients with Actinic Keratosis: A Randomized, Open-Label, Prospective, Multicentric Study"],"prefix":"10.1007","volume":"16","author":[{"given":"Marco","family":"Ardig\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Burlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Campione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Nazzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Foggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8099-0192","authenticated-orcid":false,"given":"Francesca","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Alfano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo V.","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"1881_CR1","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s13555-020-00425-4","volume":"10","author":"J Piquero-Casals","year":"2020","unstructured":"Piquero-Casals J, Morgado-Carrasco D, Gilaberte Y, et al. Management pearls on the treatment of actinic keratoses and field cancerization. Dermatol Ther (Heidelb). 2020;10:903\u201315. https:\/\/doi.org\/10.1007\/s13555-020-00425-4.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1881_CR2","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.jaad.2012.09.053","volume":"68","author":"B Berman","year":"2013","unstructured":"Berman B, Cockerell CJ. Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation. J Am Acad Dermatol. 2013;68:S10\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2012.09.053.","journal-title":"J Am Acad Dermatol"},{"key":"1881_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13179","author":"RN Werner","year":"2015","unstructured":"Werner RN, Jacobs A, Rosumeck S, Erdmann R, Sporbeck B, Nast A. Methods and results report\u2014evidence and consensus-based (S3) guidelines for the treatment of actinic keratosis\u2014International League of Dermatological Societies in cooperation with the European Dermatology Forum. J Eur Acad Dermatol Venereol. 2015. https:\/\/doi.org\/10.1111\/jdv.13179.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1881_CR4","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jaad.2021.04.017","volume":"86","author":"T Steeb","year":"2022","unstructured":"Steeb T, Wessely A, Petzold A, et al. Long-term recurrence rates of actinic keratosis: a systematic review and pooled analysis of randomized controlled trials. J Am Acad Dermatol. 2022;86:1116\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2021.04.017.","journal-title":"J Am Acad Dermatol"},{"key":"1881_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/nu13010153","volume":"13","author":"HB Everts","year":"2021","unstructured":"Everts HB, Akuailou E-N. Retinoids in cutaneous squamous cell carcinoma. Nutrients. 2021;13:153. https:\/\/doi.org\/10.3390\/nu13010153.","journal-title":"Nutrients"},{"key":"1881_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012622","volume":"23","author":"B Ramchatesingh","year":"2022","unstructured":"Ramchatesingh B, Mart\u00ednez Villarreal A, Arcuri D, et al. The use of retinoids for the prevention and treatment of skin cancers: an updated review. Int J Mol Sci. 2022;23:12622. https:\/\/doi.org\/10.3390\/ijms232012622.","journal-title":"Int J Mol Sci"},{"key":"1881_CR7","first-page":"949","volume":"6","author":"TE Moon","year":"1997","unstructured":"Moon TE, Levine N, Cartmel B, et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev. 1997;6:949\u201356.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1881_CR8","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1158\/1078-0432.CCR-03-0188","volume":"10","author":"D Alberts","year":"2004","unstructured":"Alberts D, Ranger-Moore J, Einspahr J, et al. Safety and efficacy of dose-intensive oral vitamin\u00a0A in subjects with sun-damaged skin. Clin Cancer Res. 2004;10:1875\u201380. https:\/\/doi.org\/10.1158\/1078-0432.CCR-03-0188.","journal-title":"Clin Cancer Res"},{"key":"1881_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000481770","volume":"9","author":"V Garofalo","year":"2017","unstructured":"Garofalo V, Ventura A, Mazzilli S, et al. Treatment of multiple actinic keratosis and field of cancerization with topical piroxicam 0.8% and sunscreen 50+ in organ transplant recipients: a series of 10 cases. Case Rep Dermatol. 2017;9:211\u20136. https:\/\/doi.org\/10.1159\/000481770.","journal-title":"Case Rep Dermatol"},{"key":"1881_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/phpp.12452","volume":"35","author":"I Bobyr","year":"2019","unstructured":"Bobyr I, Campanati A, Giacchetti A, Offidani A. Fluorescent photodiagnostic evaluation of field cancerization treated with a medical device containing piroxicam 0.8% and sunscreen SPF 50+ for actinic keratosis. Photodermatol Photoimmunol Photomed. 2019;35:277\u20139. https:\/\/doi.org\/10.1111\/phpp.12452.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"1881_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1080\/03007995.2016.1174678","volume":"32","author":"G Babino","year":"2016","unstructured":"Babino G, Diluvio L, Bianchi L, et al. Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study. Curr Med Res Opin. 2016;32:1345\u20139. https:\/\/doi.org\/10.1080\/03007995.2016.1174678.","journal-title":"Curr Med Res Opin"},{"key":"1881_CR12","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1080\/03007995.2019.1626227","volume":"35","author":"M Agozzino","year":"2019","unstructured":"Agozzino M, Russo T, Franceschini C, et al. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial. Curr Med Res Opin. 2019;35:1785\u201392. https:\/\/doi.org\/10.1080\/03007995.2019.1626227.","journal-title":"Curr Med Res Opin"},{"key":"1881_CR13","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1080\/03007995.2017.1313212","volume":"33","author":"M Puviani","year":"2017","unstructured":"Puviani M, Galloni C, Marchetti S, et al. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3\u00a0month trial. Curr Med Res Opin. 2017;33:1255\u20139. https:\/\/doi.org\/10.1080\/03007995.2017.1313212.","journal-title":"Curr Med Res Opin"},{"key":"1881_CR14","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/jdv.14267","volume":"31","author":"T Dirschka","year":"2017","unstructured":"Dirschka T, Pellacani G, Micali G, et al. A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index. J Eur Acad Dermatol Venereol. 2017;31:1295\u2013302. https:\/\/doi.org\/10.1111\/jdv.14267.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1881_CR15","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/s13555-025-01455-6","volume":"15","author":"F Bulla","year":"2025","unstructured":"Bulla F, Mej\u00eda S, Gil-Qui\u00f1ones S, Cata\u00f1o S, Sierra S. Effect of a photolyase-based medical device on actinic keratosis in phototypes III\u2013IV patients: real-life clinical setting. Dermatol Ther (Heidelb). 2025;15:2131\u201345. https:\/\/doi.org\/10.1007\/s13555-025-01455-6.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1881_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.987696","author":"F Veronese","year":"2022","unstructured":"Veronese F, Seoni S, Tarantino V, et al. AKASI and near-infrared spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients. Front Med (Lausanne). 2022. https:\/\/doi.org\/10.3389\/fmed.2022.987696.","journal-title":"Front Med (Lausanne)"},{"key":"1881_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2165\/11311170-000000000-00000","volume":"11","author":"E Campione","year":"2010","unstructured":"Campione E, Diluvio L, Patern\u00f2 EJ, Chimenti S. Topical treatment of actinic keratoses with piroxicam 1% gel. Am J Clin Dermatol. 2010;11:45\u201350. https:\/\/doi.org\/10.2165\/11311170-000000000-00000.","journal-title":"Am J Clin Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01881-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01881-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01881-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:21:32Z","timestamp":1788981692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01881-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1881"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01881-0","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"5 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Massimo Milani, Stefano Alfano, and Francesca Colombo are employees of Cantabria Labs Difa Cooper that commercialized the tested products. Marco Ardig\u00f2, Martina Burlando, Elena Campione, Gianluca Nazzaro, Giulio Foggi, and Angelo V. Marzano, declare no conflicts of interest related to this manuscript.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with Good Clinical Practice guidelines and the ethical principles of the Declaration of Helsinki and its later amendments. The study protocol was approved by an external independent review board in January 2023 (DC-01-2023, 12 January 2023). The trial registration number is ISRCTN42565762. Before enrolment, all participants provided fully informed written consent to participate in the study and for the publication of their clinical photographs.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}